semaglutide to tirzepatide transition How Switch from to Switching from semaglutide to tirzepatide

While serious liver complications from GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists are uncommon, patients and healthcare providers should remain alert to potential warning signs that warrant medical evaluation

Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants

HIDRADENITIS suppurativa (HS) is closely linked with excess weight: around half of patients are overweight or living with obesity

This article examines the proposed rationale behind combining these peptides, the significant safety concerns and regulatory risks involved, and the evidence-based, MHRA-approved alternatives available to people in the UK seeking medically supervised weight management

During your consultation, we will discuss a schedule of B12 injections thats right for you

Additional Benefits: Many GLP-1 agonists offer cardiovascular and kidney health benefits, which may influence your decision